Urolithin A
Gut-microbiota-derived ellagitannin metabolite with a preliminary RCT signal for muscle endurance; trials are small, short and mixed.
- Evidence
- Preliminary evidenceGRADE certainty: Low
- Typical dose
- 500–1,000 mg/day, single dose
- Time to effect
- Muscle endurance effect over 4 months in the published trial
- Safety
- Has documented cautions
Evidence ratings summarise published research on Urolithin A in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Urolithin A
Interactions
Taking any medication?
Check Urolithin A against it.
Why
Urolithin A is produced by gut microbiota from dietary ellagitannins in pomegranate, walnuts and berries. About 40% of people have the gut bacteria to produce it endogenously, non-producers must consume it directly. A systematic review of five small studies (250 healthy people) found increased muscle strength and endurance and changes in some mitochondrial and autophagy-related genes, but no change in maximal ATP production or physical function. A 4-month trial in adults aged 65–90 (n=66) found better muscle endurance than placebo, while in trained runners (n=42) running performance was not significantly improved. Disease-endpoint outcome data is not yet available.
How it works
Proposed mitophagy inducer: promotes clearance of damaged mitochondria via the PINK1/Parkin pathway in animal and cell models. This has not been established as a clinical benefit in humans.
Expected onset · Muscle endurance effect over 4 months in the published trial
How to take
Dosage
500–1,000 mg/day, single dose. Trials use 500 mg/day for endurance endpoints.
Timing
Once daily with food
On the label
Stated urolithin A content per dose; the trials used a purified preparation at 500–1,000 mg. Dietary precursors (pomegranate, walnuts, berries) produce urolithin A only in the ~40% of people with the right gut microbiota.
Studied in
Older adults curious about muscle endurance; people with low natural urolithin A production (non-producer phenotype).
Safety
Evidence
Kuerec 2024 Ageing Research Reviews systematic review (5 studies, 250 healthy people): urolithin A increased muscle strength and endurance and upregulated some mitochondrial and autophagy-related genes, but did not change maximal ATP production or physical function. A 4-month trial in adults aged 65-90 (n=66) found better muscle endurance than placebo; a trial in trained runners (n=42) found no significant improvement in 3000 m performance.
GRADE certainty: Low — rated by Healicus using the GRADE method
First-in-class mitophagy supplement, long-term outcome data not yet available. No Cochrane review, no EMA monograph. Cost is high relative to other longevity supplements.
- Liu S et al., Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial, JAMA Netw Open 2022
- Kuerec AH et al., Targeting aging with urolithin A in humans: A systematic review, Ageing Res Rev 2024
- Zhao H et al., Assessment of Urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism in male athletes with resistance training: an 8-week randomized, double-blind, placebo-controlled study, J Int Soc Sports Nutr 2024
- Whitfield J et al., Evaluating the Impact of Urolithin A Supplementation on Running Performance, Recovery, and Mitochondrial Biomarkers in Highly Trained Male Distance Runners, Sports Med 2025
- Denk D et al., Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial, Nat Aging 2025
Questions people ask
Does Urolithin A work?
Kuerec 2024 Ageing Research Reviews systematic review (5 studies, 250 healthy people): urolithin A increased muscle strength and endurance and upregulated some mitochondrial and autophagy-related genes, but did not change maximal ATP production or physical function. A 4-month trial in adults aged 65-90 (n=66) found better muscle endurance than placebo; a trial in trained runners (n=42) found no significant improvement in 3000 m performance. Certainty of the evidence: Low, rated by Healicus using the GRADE method.
How is Urolithin A taken?
500–1,000 mg/day, single dose. Trials use 500 mg/day for endurance endpoints. Timing: Once daily with food. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Few side effects were reported in trials so far; long-term safety beyond 4 months is not established. Theoretical interaction with chemotherapy via mitophagy modulation, relevant to discuss with the oncology team. Pregnancy and breastfeeding: no data; avoid. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: Liu S et al., Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial, JAMA Netw Open 2022; Kuerec AH et al., Targeting aging with urolithin A in humans: A systematic review, Ageing Res Rev 2024; Zhao H et al., Assessment of Urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism in male athletes with resistance training: an 8-week randomized, double-blind, placebo-controlled study, J Int Soc Sports Nutr 2024; Whitfield J et al., Evaluating the Impact of Urolithin A Supplementation on Running Performance, Recovery, and Mitochondrial Biomarkers in Highly Trained Male Distance Runners, Sports Med 2025; Denk D et al., Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial, Nat Aging 2025.
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.